Published in Leukemia on September 01, 2005
The genetic architecture of multiple myeloma. Nat Rev Cancer (2012) 3.71
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia (2011) 1.77
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res (2010) 1.39
Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res (2008) 1.19
MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biol Direct (2011) 1.10
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context. Haematologica (2009) 1.05
The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance. Haematologica (2010) 0.98
The genetic architecture of multiple myeloma. Adv Hematol (2014) 0.96
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case. Haematologica (2009) 0.95
Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma. Oncol Lett (2014) 0.89
Impact of genetic abnormalities on the prognoses and clinical parameters of patients with multiple myeloma. Ann Lab Med (2013) 0.87
Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System. Blood (2015) 0.86
Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence. J Mol Diagn (2006) 0.84
Multiple myeloma in the very old: an IASIA conference report. J Natl Cancer Inst (2014) 0.83
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. Haematologica (2014) 0.82
Genomic complexity of multiple myeloma and its clinical implications. Nat Rev Clin Oncol (2016) 0.81
The RAG Model: A New Paradigm for Genetic Risk Stratification in Multiple Myeloma. Bone Marrow Res (2014) 0.77
Evaluation of 13q14 status in multiple myeloma by digital single nucleotide polymorphism technology. J Mol Diagn (2009) 0.75
Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India. Indian J Med Res (2016) 0.75
Complex IGH rearrangements in multiple myeloma: Frequent detection discrepancies among three different probe sets. Genes Chromosomes Cancer (2014) 0.75
Challenges and Promises of Genetic Stratification of Risk in Multiple Myeloma. Indian J Hematol Blood Transfus (2017) 0.75
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet (1998) 19.31
Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA (2001) 13.36
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med (2013) 8.89
Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ (2000) 8.44
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89
In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int J Pept Protein Res (1993) 5.82
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood (2001) 4.76
Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA (1998) 4.73
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess (1999) 4.45
Reducing antibiotics for respiratory tract symptoms in primary care: consolidating 'why' and considering 'how'. Br J Gen Pract (1998) 4.34
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Is your 'double-blind' design truly double-blind? Br J Psychiatry (1989) 3.98
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet (1998) 3.94
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia (2002) 3.90
Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr (1997) 3.63
Adolescent patients in an Inner London general practice: their attitudes to illness and health care. J R Coll Gen Pract (1984) 3.31
BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology (Oxford) (2006) 3.22
Mutations and prognosis in primary myelofibrosis. Leukemia (2013) 3.13
Elderly patients discharged from an accident and emergency department--their dependency and support. Arch Emerg Med (1984) 2.96
Moving towards evidence based emergency medicine: use of a structured critical appraisal journal club. J Accid Emerg Med (1998) 2.93
Medication, chronic illness and identity: the perspective of people with asthma. Soc Sci Med (1997) 2.88
The relationship between access and quality of urban green space with population physical activity. Public Health (2006) 2.85
Quadriceps weakness in knee osteoarthritis: the effect on pain and disability. Ann Rheum Dis (1998) 2.77
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76
Amplification of DNA from native populations of soil bacteria by using the polymerase chain reaction. Appl Environ Microbiol (1992) 2.73
Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J (1995) 2.73
Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis (2004) 2.64
Qualitative interview study of communication between parents and children about maternal breast cancer. BMJ (2000) 2.60
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
Radiographic patterns and associations of osteoarthritis of the knee in patients referred to hospital. Ann Rheum Dis (1993) 2.38
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia (2005) 2.35
Is screening for tuberculosis acceptable to immigrants? A qualitative study. J Public Health (Oxf) (2006) 2.28
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Ingrowing toenails: the results of treatment. Br J Surg (1979) 2.17
Incision of ultraviolet-irradiated DNA by extracts of E. coli requires three different gene products. Nature (1976) 2.12
Segmentation of confocal microscope images of cell nuclei in thick tissue sections. J Microsc (1999) 2.12
Urological day case surgery in elderly and medically unfit patients using sedoanalgesia: what are the limits? Br J Urol (1995) 2.10
Serum free light chains for monitoring multiple myeloma. Br J Haematol (2004) 2.07
Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol (2006) 2.06
Sustained outcomes of a peer-taught family education program on mental illness. Acta Psychiatr Scand (2012) 2.06
Directed evolution of a fungal peroxidase. Nat Biotechnol (1999) 2.04
Initial frequency of alleles for resistance to Bacillus thuringiensis toxins in field populations of Heliothis virescens. Proc Natl Acad Sci U S A (1997) 2.03
Induction of labor and the relationship to cesarean delivery: A review of 7001 consecutive inductions. Am J Obstet Gynecol (1999) 2.02
Factors affecting radiographic progression of knee osteoarthritis. Ann Rheum Dis (1995) 2.02
Adjuvant treatment in high-risk breast cancer. Br J Hosp Med (1996) 2.01
Radiographic assessment of symptomatic knee osteoarthritis in the community: definitions and normal joint space. Ann Rheum Dis (1998) 2.01
Distribution, diversity and evolution of the bacterial mercury resistance (mer) operon. FEMS Microbiol Rev (1997) 2.00
The parallel rural community curriculum: an integrated clinical curriculum based in rural general practice. Med Educ (2000) 1.98
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. Leukemia (2006) 1.95
Direct measurement of quantal changes underlying long-term potentiation in CA1 hippocampus. Neuron (1992) 1.94
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93
Exotic pets. Vet Rec (2000) 1.93
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.88
Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol (1999) 1.84
"Campylobacter cinaedi" bacteremia: case report and laboratory findings. J Clin Microbiol (1987) 1.83
Waiting times and patient satisfaction in the accident and emergency department. Arch Emerg Med (1992) 1.82
A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus (1992) 1.79
A pathway for the evolution of the plasmid NTP16 involving the novel kanamycin resistance transposon Tn4352. Plasmid (1987) 1.79
Palliative care in stroke: a critical review of the literature. Palliat Med (2007) 1.79
Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer (2004) 1.77
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia (2011) 1.77
Psychological problems following ICU treatment. Anaesthesia (2001) 1.76
Harmonization of molecular monitoring of CML therapy in Europe. Leukemia (2009) 1.76
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.72
Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol (2007) 1.72
Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074. Leukemia (2004) 1.71
Kawasaki disease in Canterbury. Arch Dis Child (1978) 1.70
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia (2006) 1.69
Helping students learn to think like experts when solving clinical problems. Acad Med (1997) 1.68
Local anaesthesia for vitreoretinal surgery: a case-control study of 200 cases. Eye (Lond) (1998) 1.67
Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J Exp Med (1998) 1.67
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
Multilevel models and health economics. Health Econ (1998) 1.63
Imatinib for systemic mast-cell disease. Lancet (2003) 1.62
Death and dying: attitudes in a teaching hospital. Urology (1974) 1.59
Paracetamol (acetaminophen) poisoning. No need to change current guidelines to accident departments. BMJ (1998) 1.57
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia (2002) 1.54
Concordance between clinician and patient assessment of physical and mental health status. J Rheumatol (1992) 1.53
32P-incorporation PCR for the detection of rearrangements at the TCR-gamma locus. Diagn Mol Pathol (1996) 1.52
Nijmegen breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer (2005) 1.50
Bromocriptine treatment of female infertility: report of 13 pregnancies. Br Med J (1975) 1.49
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol (1995) 1.48
Excision repair of ultraviolet-irradiated deoxyribonucleic acid in plasmolyzed cells of Escherichia coli. J Bacteriol (1976) 1.48
A simple assessment method for auditing multi-centre unilateral cleft lip repairs. J Plast Reconstr Aesthet Surg (2010) 1.47
Quantitative assessment of full range-of-motion isometric lumbar extension strength. Spine (Phila Pa 1976) (1990) 1.47
Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol (1991) 1.47
Tumour necrosis factor in man: clinical and biological observations. Br J Cancer (1987) 1.46
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Leukemia (2011) 1.45
One-stage hypospadias repair. Experience with 544 cases. Eur Urol (1999) 1.45
Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol (1997) 1.45